NRC Health Non Peo Neo Avg Total Comp Amt
NRC Health (NRC) reported Non Peo Neo Avg Total Comp Amt of $1.62 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-05-08.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-05-08
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $1.62M DEF 14A · filed 2026-05-08 |
| 2024-12-31 | $1.12M DEF 14A · filed 2026-05-08 |
| 2023-12-31 | $428.16K DEF 14A · filed 2026-05-08 |
| 2022-12-31 | $410.11K DEF 14A · filed 2026-05-08 |
| 2021-12-31 | $490.47K DEF 14A · filed 2026-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |